| 发明名称 | Diagnosis of acute coronary syndrome, myocardial infarction, or angina pectoris by means of neurophysin II | ||
| 摘要 | The invention relates to methods for in vitro diagnosis of acute coronary syndrome (ACS), acute myocardial infarction (AMI) or angina pectoris (AP) by determining the level of neurophysin II in a sample from a patient. | ||
| 申请公布号 | US9261517(B2) | 申请公布日期 | 2016.02.16 |
| 申请号 | US201313951084 | 申请日期 | 2013.07.25 |
| 申请人 | B.R.A.H.M.S GmbH | 发明人 | Bergmann Andreas;Morgenthaler Nils;Papassotiriou Jana;Struck Joachim;Ng Leong L. |
| 分类号 | G01N33/68;G01N33/74 | 主分类号 | G01N33/68 |
| 代理机构 | Novak Druce Connolly Bove + Quigg LLP | 代理人 | Novak Druce Connolly Bove + Quigg LLP |
| 主权项 | 1. A method for in vitro diagnosis of acute coronary syndrome, myocardial infarction, or angina pectoris, comprising a) determining the level of neurophysin II in at least one sample from a patient, wherein said neurophysin II is a fragment of preprovasopressin, said fragment consisting of the polypeptide of SEQ ID NO: 2; and b) diagnosing the presence of acute coronary syndrome, myocardial infarction or angina pectoris in said patient based on the result in step a) . | ||
| 地址 | Hennigsdorf DE | ||